What is SUNVEPRA (asunaprevir) for hepatitis C treatment?
Sunvepra capsules function by exerting inhibitory effects on a specific protease enzyme that plays a crucial role in the replication process of the hepatitis C virus (HCV). This mechanism of action targets a vital step in the viral life cycle, impeding the virus's ability to replicate and proliferate effectively within the host's cells. As a result of this targeted inhibition, Sunvepra demonstrates antiviral effects against hepatitis C.
The medicine's effectiveness is further enhanced when it is administered concomitantly with other antiviral agents, such as daclatasvir (marketed as Daklinza) and ribavirin. This combination therapy capitalizes on the synergistic effects of these medications, leading to a more comprehensive suppression of HCV replication.
Sunvepra capsules find their primary application in the management of chronic hepatitis C, a persistent viral infection that can lead to significant liver-related complications over time. Additionally, the medication proves beneficial in cases of compensated cirrhosis type C, a condition where liver function is compromised but not yet decompensated to the point of severe dysfunction. By targeting the underlying viral infection and its replication process, Sunvepra contributes to the overall reduction of viral load and the potential improvement of liver health.
Active principles: asunaprevir
Amount: 28 capsules
Maker: Bristol-Myers Squibb, Tokyo, Japan
Indications: chronic hepatitis C, compensated cirrhosis type C.
How to take
Adults should take 1 capsule (100 mg of active principle) at a time, 2 times a day. It is used concomitantly with daclatasvir, and duration of medication is 24 weeks.
Never take the second dose less than 4 hours after taking the previous one.
Contraindications: do not use for patients with liver dysfunction, with hepatitis B virus (HBV) infection or a history of HBV infection. Do not use for pregnant, possibly pregnant or breastfeeding women.
Avoid taking any food or health supplement containing St. John's wort while taking this medicine.
Take an adequate birth control if this medicine is used concomitantly with daclatasvir.
If an allergic reaction occurs, patient needs to stop using the medicine and consult with their doctor. If patient is taking any other medication or treatment, they should consult with their doctor in advance.